Effects of omalizumab therapy on peripheral nerve functions: short observational study

YAVUZ G., YıLGÖR A., Yavuz I., MILANLıOĞLU A., ÇILINGIR V., ÇAĞAÇ A., ...Daha Fazla

POSTEPY DERMATOLOGII I ALERGOLOGII, cilt.36, sa.2, ss.211-216, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 2
  • Basım Tarihi: 2019
  • Doi Numarası: 10.5114/ada.2018.74834
  • Dergi Adı: POSTEPY DERMATOLOGII I ALERGOLOGII
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.211-216
  • Anahtar Kelimeler: chronic urticaria, omalizumab, neuropathy, INFLAMMATORY DEMYELINATING POLYNEUROPATHY, SAFETY, TOLERABILITY, NEUROPATHY, URTICARIA, DIAGNOSIS, PATIENT
  • Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

Introduction: Peripheral neuropathy (PN) is a common neurological condition causing symmetrical and diffuse damage in nerves. The etiology of PN includes systemic diseases, toxic exposure, medications, infections, and hereditary diseases. Omalizumab is a humanized monoclonal anti-IgE antibody that exerts its activity by binding to free IgE in circulation.